Deng Wen, Chen Ru, Zhu Ke, Cheng Xiaofeng, Xiong Yunqiang, Liu Weipeng, Zhang Cheng, Li Yulei, Jiang Hao, Zhou Xiaochen, Sun Ting, Chen Luyao, Liu Xiaoqiang, Wang Gongxian, Fu Bin
Department of Urology, The First Affiliated Hospital of Nanchang University, Yongwai Street 17, Nanchang, Jiangxi Province, China.
Jiangxi Institute of Urology, Yongwai Street 17, Nanchang, Jiangxi Province, China.
J Oncol. 2021 Dec 21;2021:4375722. doi: 10.1155/2021/4375722. eCollection 2021.
To evaluate the urinary continence (UC), erectile function, and cancer control obtained following robot-assisted radical prostatectomy (RARP) and laparoscopic radical prostatectomy (LRP) for intermediate- and high-risk localized prostate cancer (PCa).
232 patients bearing intermediate- and high-risk localized PCa were enrolled in this study. Perioperative, functional, and oncological outcomes were analyzed after applying the propensity score matched method.
Within the matched cohort, the RARP group was corrected with a significantly shorter mean operative time than the LRP group ( < 0.001). Patients in the RARP arm were also at a lower risk of ≤ Grade II complications than those in the LRP group ( = 0.036). Meanwhile, the proportions of transfusion and ≥ Grade II complications in the RARP group were similar to those in the LRP group ( = 0.192 and = 1.000, respectively). No significant differences regarding the rates of pT3 disease and positive surgical margin existed between the two groups. RARP versus LRP tended to a significantly higher percentage of UC recovery within the follow-up period. Significant differences were also found between the RARP and LRP arms in terms of erectile function at postoperative 6 months and the last follow-up ( = 0.013 and = 0.009, respectively). Statistical comparability in biochemical recurrence-free survival was observed between the two groups ( = 0.228).
For the surgical management of intermediate- and high-risk localized PCa, RARP tended to a lower risk of ≤ Grade II complications and superior functional preservation without cancer control being compromised than LRP.
评估机器人辅助根治性前列腺切除术(RARP)和腹腔镜根治性前列腺切除术(LRP)治疗中高危局限性前列腺癌(PCa)后的尿失禁(UC)、勃起功能和癌症控制情况。
本研究纳入了232例中高危局限性PCa患者。应用倾向评分匹配法分析围手术期、功能和肿瘤学结局。
在匹配队列中,RARP组的平均手术时间明显短于LRP组(<0.001)。RARP组患者发生≤Ⅱ级并发症的风险也低于LRP组(=0.036)。同时,RARP组的输血比例和≥Ⅱ级并发症比例与LRP组相似(分别为=0.192和=1.000)。两组之间在pT3疾病发生率和手术切缘阳性率方面无显著差异。在随访期内,RARP组的UC恢复率倾向于显著高于LRP组。在术后6个月和最后一次随访时,RARP组和LRP组在勃起功能方面也存在显著差异(分别为=0.013和=0.009)。两组在无生化复发生存方面具有统计学可比性(=0.228)。
对于中高危局限性PCa的手术治疗,与LRP相比,RARP发生≤Ⅱ级并发症的风险更低,在不影响癌症控制的情况下功能保留更优。